Carbon-based materials for electrochemical sensing of SARS-CoV-2

One of the most important aspects of the development of an electrochemical biosensor is the choice of materials used in the manufacturing process. This statement is based, not only on the use of the material with a good ability to conduct electrons but also on the use of a material that provides a good linkage between the electron transducer and the biological material. In this meaning, carbon-based conductive materials have been widely used in the development of electrochemical bioassays. This is because these materials present high electrical conductivity, low current background, stability, low cost, and mainly the potentiality the use as a material biological host system, after the association with enzymes, antibodies, DNA, and RNA fragments, among others. In this respect, electrochemical biosensors have played an important role in disease diagnosis, especially in the last few years for the sensing of SARS-CoV-2. Carbon-based materials can be classified according to their dimensionalities and structures, which can influence their properties (Li and Mu in Appl Energy 242:695-715, 2019 1). In addition, surface treatments have been widely used for the activation or functionalization of carbon-based materials, which can improve sensor immobilization. Thus, the properties, treatments, and applications of carbon-based materials for the fabrication of biosensors for the detection of SARS-CoV-2 will be addressed and discussed in this chapter. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2023. All rights reserved.

Using Nanomaterials for SARS-CoV-2 Sensing via Electrochemical Techniques.

Advancing low-cost and user-friendly innovations to benefit public health is an important task of scientific and engineering research. According to the World Health Organization (WHO), electrochemical sensors are being developed for low-cost SARS-CoV-2 diagnosis, particularly in resource-limited settings. Nanostructures with sizes ranging from 10 nm to a few micrometers could deliver optimum electrochemical behavior (e.g., quick response, compact size, sensitivity and selectivity, and portability), providing an excellent alternative to the existing techniques. Therefore, nanostructures, such as metal, 1D, and 2D materials, have been successfully applied in in vitro and in vivo detection of a wide range of infectious diseases, particularly SARS-CoV-2. Electrochemical detection methods reduce the cost of electrodes, provide analytical ability to detect targets with a wide variety of nanomaterials, and are an essential strategy in biomarker sensing as they can rapidly, sensitively, and selectively detect SARS-CoV-2. The current studies in this area provide fundamental knowledge of electrochemical techniques for future applications.

Social Distancing and Social Biosensing: Intersubjectivity from Afar.

The shelter-in-place orders across the U.S. in response to the COVID-19 pandemic forced many relationships once sustained by in-person interaction into remote states through computer-mediated communication (CMC). Work, school, holidays, social engagements, and everyday conversations formerly experienced through rich and contextual in-person interactions instead have taken place on messaging, voice, and video chatting platforms that diminish or altogether lack many social cues and other qualities critical to social interaction. The difficulties feeling connected to one another observed during this period have stressed the need for novel forms of communication that enable deeper interactions. Social biosensing, the interpersonal sharing of physiological information, has shown promise facilitating social connection at a distance. In the present research we document the experiences of nine pairs of friends (N = 18) who navigated living through a shelter-in-place order, reporting on their experiences sharing their electrodermal activity (EDA) in response to short videos. Participants described the artificial and unnatural nature of communicating using typical forms of CMC and a range of interpretations of EDA as both emotional response and as representative of personal characteristics. We implemented a phased approach to study the temporal nature of forming an understanding of unfamiliar yet intimate data like EDA. Our results indicate typologies of meaning-making processes: "stablers", "broadeners", and "puzzlers". We also interpreted our findings through the lens of intersubjectivity, analyzing how analogical apperception and dialogical interaction both play a role in participants' meaning-making about their own and their partner's biosensory information. We conclude with implications from this work pertinent to intersubjectivity theorists, social biosensing researchers, and CMC system designers and developers.

Recent advances on CRISPR/Cas system-enabled portable detection devices for on-site agri-food safety assay

Agri-food safety has been considered as one of the most important public concerns worldwide. From farm to table, food crops and foods are extremely vulnerable to the contamination by a variety of pollutants from their growth and processing. Moreover, the SARS-CoV-2 detected in the food supply chain during COVID-19 pandemic has posed a greater challenge for rapid and on-site detection of agri-food contaminants in complex and volatile environments. Therefore, the development of rapid, accurate, and on-site detection technologies and portable detection devices is of great importance to ensure the agri-food security. This review comprehensively summarized the recent advances on the construction of CRISPR/Cas systems-based biosensing technologies and their portable detection devices, as well as their promising applications in the field of agri-food safety. First of all, the classification and working principles of CRISPR/Cas systems were introduced. Then, the latest advances on the CRISPR/Cas system-based on-site detection technologies and portable detection devices were also systematically summarized. Most importantly, the state-of-the-art applications of CRISPR/Cas systems-based on-site detection technologies and portable detection devices in the fields of agri-food safety were comprehensively summarized. Impressively, the future opportunities and challenges in this emerging and promising field were proposed. Emerging CRISPR/Cas system-based on-site detection technologies have showed a great potential in the detection of agri-food safety. Impressively, the integration of CRISPR/Cas systems-based biosensing technologies with portable detection devices (e.g., nanopore-based detection devices, lateral flow assay, smartphone-based detection devices, and microfluidic devices) is very promising for the on-site detection of agri-food contaminants. Additionally, CRISPR/Cas system-based biosensing technologies can be further integrated with much more innovative technologies for the development of novel detection platforms to realize the more reliable on-site detection of agri-food safety.

Programmable Nanostructures Based on Framework-DNA for Applications in Biosensing.

DNA has been actively utilized as bricks to construct exquisite nanostructures due to their unparalleled programmability. Particularly, nanostructures based on framework DNA (F-DNA) with controllable size, tailorable functionality, and precise addressability hold excellent promise for molecular biology studies and versatile tools for biosensor applications. In this review, we provide an overview of the current development of F-DNA-enabled biosensors. Firstly, we summarize the design and working principle of F-DNA-based nanodevices. Then, recent advances in their use in different kinds of target sensing with effectiveness have been exhibited. Finally, we envision potential perspectives on the future opportunities and challenges of biosensing platforms.

Viruses as biomaterials

Viruses lacking the capacity to infect mammals exhibit minimal toxicity, good biocompatibility, and well-defined structures. As self-organized biomolecular assemblies, they can be produced from standard biological techniques on a large scale at a low cost. Genetic, chemical, self-assembly, and mineralization techniques have been applied to allow them to display functional peptides or proteins, encapsulate therapeutic drugs and genes, assemble with other materials, and be conjugated with bioactive molecules, enabling them to bear different biochemical properties. So far, a variety of viruses (infecting bacteria, plants, or animals), as well as their particle variants, have been used as biomaterials to advance human disease prevention, diagnosis, and treatment. Specifically, the virus-based biomaterials can serve as multifunctional nanocarriers for targeted therapy, antimicrobial agents for infectious disease treatment, hierarchically structured scaffolds for guiding cellular differentiation and promoting tissue regeneration, versatile platforms for ultrasensitive disease detection, tissue-targeting probes for precision bioimaging, and effective vaccines and immunotherapeutic agents for tackling challenging diseases. This review provides an in-depth discussion of these exciting applications. It also gives an overview of the viruses from materials science perspectives and attempts to correlate the structures, properties, processing, and performance of virus-based biomaterials. It describes the use of virus-based biomaterials for preventing and treating COVID-19 and discusses the challenges and future directions of virus-based biomaterials research. It summarizes the progressive clinical trials of using viruses in humans. With the impressive progress made in the exciting field of virus-based biomaterials, it is clear that viruses are playing key roles in advancing important areas in biomedicine such as early detection and prevention, drug delivery, infectious disease treatment, cancer therapy, nanomedicine, and regenerative medicine. [ FROM AUTHOR] Copyright of Materials Science & Engineering: R is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

Crispr biosensing and Ai driven tools for detection and prediction of Covid-19

Coronaviridae family consists of many virulent viruses with zoonotic properties that can be transmitted from animals to humans. Different strains of these viruses have caused pandemic in the past such as Severe Respiratory Syndrome Coronavirus (SARS-CoV) in 2002, Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 and recently Severe Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) also known as COVID-19 in December 2019. Scientists utilised different approaches for the detection and characterisation of CoVs using samples such as serum, throat swabs, nose swabs, nasopharyngeal aspirates and bronchoalveolar lavages. The two common approaches include antigen-based approach and molecular diagnostic approach, which are hindered by limitations such as low sensitivity and requirement for high level of biosafety during isolation of the virus from cell culture. Thus, there is a need for developing a more rapid, sensitive, simple and cheap diagnostic kit for diagnosis of different strains of coronavirus. In this article, we overview 2019 novel coronavirus, pandemic, prior epidemics, diagnosis, treatments, identification of drugs detection based on classification and prediction using artificial intelligence-driven tools. We also overview in-lab molecular testing and on-site testing using CRISPR-based biosensing tools. We also outline limitations of laboratory techniques and open-research issues in the current state of CRISPR-based biosensing applications and artificial intelligence for treatment of Coronaviruses. [ FROM AUTHOR] Copyright of Journal of Experimental & Theoretical Artificial Intelligence is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

Dual-comb biosensing of SARS-CoV-2 nucleocapsid protein antigen

One interesting feature of optical frequency comb (OFC) is a function of frequency conversion between region and electric regions. While such feature has been used for generation of correct electric signal in microwave or millimeter region, it can be further used for fiber biosensing;namely, biosensing OFC. In this paper, we demonstrated detection of SARS-CoV-2 antigen based on a combination of dual fiber combs, an intracavity multi-mode-interference fiber sensor, and sensor surface modification of SARS-CoV-2 antibody. © COPYRIGHT SPIE. Downloading of the is permitted for personal use only.

CRISPR-Cas assisted diagnostics: A broad application biosensing approach

In addition to its remarkable genome editing capability, the CRISPR-Cas system has proven to be very effective in many fields of application, including the biosensing of pathogenic infections, mutagenic defects, or early cancer diagnosis. Thanks to their many advantages in terms of simplicity, efficiency, and reduced time, several CRISPR-Cas systems have been described for the design of sensitive and selective analytical tools, paving the way for the development and further commercialization of next-generation diagnostics. However, CRISPR-Cas-based biosensors still need further research efforts to improve some drawbacks, such as the need for target amplification, low reproducibility, and lack of knowledge of exploited element robustness. This review aims to describe the latest trends in the design of CRISPR-Cas biosensing technologies to better highlight the insights of their advantages and to point out the limitations that still need to be overcome for their future market entry as medical diagnostics.Copyright © 2023 Elsevier B.V.

Healthcare Science for Lifelong Health-Visualizing Biological Rhythms and Regulating Them on One's Own

The COVID-19 pandemic has brought dramatic changes to our daily lives and social activities. Anxiety over one and one's family becoming infected, stress caused by limitations imposed on personal behavior, changes in lifestyle, etc. have greatly affected everyone's mental and physical condition. This article introduces health science that aims for a society of lifelong health by visualizing one's daily data covering basic lifestyle habits (eating, exercising, and sleeping) and self-regulating one's biological rhythms. © 2022 Nippon Telegraph and Telephone Corp.. All rights reserved.

High sensitivity and selectivity vertically-oriented silicon nanowire array-based bioelectronic sensor platform

Silicon nanowires are next-generation high performance biosensor materials compatible with multiple types of biomolecules. Bioelectronic sensors, which output electrical signals for biological detection, have unique advantages in miniaturization, fast response, and portability. Despite that these nanomaterials have demonstrated high performance, complex fabrication methods that are not compatible with industrial production are usually implemented. This work deals with the development, fabrication, and testing of a rapid and cost-effective silicon nanowire biosensor that is less than one inch in width and suited for industrial mass production. The silicon nanowires are fabricated using a silver-assisted chemical etching which can be mass-producible and CMOS-compatible, tunable etch rate, and high consistency. The nanowire sensor is then fabricated using a series of nanofabrication instruments that are commonly used for semiconductor processing. The fabrication process is developed and modified to be suited for biosensing applications, and the scanning electron microscopy demonstrates that the fabricated sensor has etched vertical silicon nanowire arrays of around 350 nm in length and 1010 per 1 cm2 in density.The fabricated vertically-oriented silicon nanowire array-based sensor consists of a p-n diode. Since the diode type nanowire biosensors have not been thoroughly implemented and studied, in this work, in order to simulate and validate the operation mechanisms of the proposed biosensor, an operation protocol is proposed to characterize the sensor by measuring its current as a function of the applied voltage and calculating the derivative the current-voltage function. Then the mathematical and physical models of the device are studied, and a water-gate experiment is conducted to justify the models. In the case when the unexpected disturbance occurs, the model also provides with a method to eliminate the noise in the effective resistance of the sensor.The fabricated biosensors are then functionalized for the testing of three types of analytes including two cancer cell antibodies and the spike protein of the severe acute respiratory syndrome coronavirus 2. The results show that the developed sensors have high sensitivity and specificity against bovine serum albumin. Although still with a preliminary design, the proposed sensor has already been demonstrated to be able to detect clinically relevant concentrations of the target for the diagnosis of the disease. This technology offers the potential to complement conventional biosensor systems in applications of portable and rapid responding biosensing. (PsycInfo Database Record (c) 2022 APA, all rights reserved)

Viruses as biomaterials

Viruses lacking the capacity to infect mammals exhibit minimal toxicity, good biocompatibility, and well-defined structures. As self-organized biomolecular assemblies, they can be produced from standard biological techniques on a large scale at a low cost. Genetic, chemical, self-assembly, and mineralization techniques have been applied to allow them to display functional peptides or proteins, encapsulate therapeutic drugs and genes, assemble with other materials, and be conjugated with bioactive molecules, enabling them to bear different biochemical properties. So far, a variety of viruses (infecting bacteria, plants, or animals), as well as their particle variants, have been used as biomaterials to advance human disease prevention, diagnosis, and treatment. Specifically, the virus-based biomaterials can serve as multifunctional nanocarriers for targeted therapy, antimicrobial agents for infectious disease treatment, hierarchically structured scaffolds for guiding cellular differentiation and promoting tissue regeneration, versatile platforms for ultrasensitive disease detection, tissue-targeting probes for precision bioimaging, and effective vaccines and immunotherapeutic agents for tackling challenging diseases. This review provides an in-depth discussion of these exciting applications. It also gives an overview of the viruses from materials science perspectives and attempts to correlate the structures, properties, processing, and performance of virus-based biomaterials. It describes the use of virus-based biomaterials for preventing and treating COVID-19 and discusses the challenges and future directions of virus-based biomaterials research. It summarizes the progressive clinical trials of using viruses in humans. With the impressive progress made in the exciting field of virus-based biomaterials, it is clear that viruses are playing key roles in advancing important areas in biomedicine such as early detection and prevention, drug delivery, infectious disease treatment, cancer therapy, nanomedicine, and regenerative medicine. © 2023 Elsevier B.V.

The application of nano-biosensors in the detection of 2019-nCoV.

The pandemic of 2019 novel coronavirus (2019-nCoV) infection since 2020 caused Coronavirus Disease 2019 (COVID-19) leads the serious threaten to global public health. It is urgent to diagnose COVID-19, guide epidemiological measures, control the infection rates, research/develop the antiviral treatment and promote the vaccine research. The application of nano-material based biosensors (the nano-biosensors) has achieved the high-performance detection of a variety of biomarkers due to their small device size, label free detection, high sensitivity, good specificity, short detection time, and has been considered as great potential to become a point-of-care testing tool for detecting 2019-nCoV. Therefore, by summarizing the working principle and classification of nano-biosensors, and focusing on the research progress of nano-biosensors in the detection of 2019-nCoV reported in the recent years, our review provides the challenges and future development prospects of the nano-biosensor in clinical laboratory.Copyright © 2022 Chin J Lab Med. All rights reserved.

Highly Sensitive and Specific SARS-CoV-2 Serological Assay Using a Magnetic Modulation Biosensing System.

Sensitive serological assays are needed to provide valuable information about acute and past viral infections. For example, detection of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibodies could serve as the basis for an "immunity passport" that would enable individuals to travel internationally. Here, utilizing a novel Magnetic Modulation Biosensing (MMB) system and the receptor-binding domain of the SARS-CoV-2 spike protein, we demonstrate a highly sensitive and specific anti-SARS-CoV-2 IgG serological assay. Using anti-SARS-CoV-2 IgG antibodies, RT-qPCR SARS-CoV-2-positive and healthy patients' samples, and vaccinees' samples, we compare the MMB-based SARS-CoV-2 IgG assay's analytical and clinical sensitivities to those of the enzyme-linked immunosorbent assay (ELISA). Compared with ELISA, the MMB-based assay has an ~6-fold lower limit of detection (129 ng/L vs. 817 ng/L), and it detects an increase in the IgG concentration much earlier after vaccination. Using 85 RT-qPCR SARS-CoV-2-positive samples and 79 -negative samples, the MMB-based assay demonstrated similar clinical specificity (98% vs. 99%) and sensitivity (93% vs. 92%) to the ELISA test, but with a much faster turnaround time (45 min vs. 245 min). The high analytical and clinical sensitivity, short turnaround time, and simplicity of the MMB-based assay makes it a preferred method for antibody detection.

Recent Trends in SERS-Based Plasmonic Sensors for Disease Diagnostics, Biomolecules Detection, and Machine Learning Techniques.

Surface-enhanced Raman spectroscopy/scattering (SERS) has evolved into a popular tool for applications in biology and medicine owing to its ease-of-use, non-destructive, and label-free approach. Advances in plasmonics and instrumentation have enabled the realization of SERS's full potential for the trace detection of biomolecules, disease diagnostics, and monitoring. We provide a brief review on the recent developments in the SERS technique for biosensing applications, with a particular focus on machine learning techniques used for the same. Initially, the article discusses the need for plasmonic sensors in biology and the advantage of SERS over existing techniques. In the later sections, the applications are organized as SERS-based biosensing for disease diagnosis focusing on cancer identification and respiratory diseases, including the recent SARS-CoV-2 detection. We then discuss progress in sensing microorganisms, such as bacteria, with a particular focus on plasmonic sensors for detecting biohazardous materials in view of homeland security. At the end of the article, we focus on machine learning techniques for the (a) identification, (b) classification, and (c) quantification in SERS for biology applications. The review covers the work from 2010 onwards, and the language is simplified to suit the needs of the interdisciplinary audience.

Molecular imprinting-based sensors: Lab-on-chip integration and biomedical applications.

The innovative technology of a marketable lab-on-a-chip platform for point-of-care (POC) in vitro detection has recently attracted remarkable attention. The POC tests can significantly enhance the high standard of medicinal care. In the last decade, clinical diagnostic technology has been broadly advanced and successfully performed in several areas. It seems that lab-on-a-chip approaches play a significant role in these technologies. However, high-cost and time-consuming methods are increasing the challenge and the development of a cost-effective, rapid and efficient method for the detection of biomolecules is urgently needed. Recently, polymer-coated sensing platforms have been a promising area that can be employed in medical diagnosis, pharmaceutical bioassays, and environmental monitoring. The designed on-chip sensors are based on molecular imprinting polymers (MIPs) that use label-free detection technology. Molecular imprinting shines out as a potentially promising technique for creating artificial recognition material with molecular recognition sites. MIPs provide unique advantages such as excellent recognition specificity, high selectivity, and good reusability. This review article aims to define several methods using molecular imprinting for biomolecules and their incorporation with several lab-on-chip technologies to describe the most promising methods for the development of sensing systems based on molecularly imprinted polymers. The higher selectivity, more user-friendly operation is believed to provide MIP-based lab-on-a-chip devices with great potential academic and commercial value in on-site clinical diagnostics and other point-of-care assays.

Integrating Water Purification with Electrochemical Aptamer Sensing for Detecting SARS-CoV-2 in Wastewater.

Wastewater analysis of pathogens, particularly SARS-CoV-2, is instrumental in tracking and monitoring infectious diseases in a population. This method can be used to generate early warnings regarding the onset of an infectious disease and predict the associated infection trends. Currently, wastewater analysis of SARS-CoV-2 is almost exclusively performed using polymerase chain reaction for the amplification-based detection of viral RNA at centralized laboratories. Despite the development of several biosensing technologies offering point-of-care solutions for analyzing SARS-CoV-2 in clinical samples, these remain elusive for wastewater analysis due to the low levels of the virus and the interference caused by the wastewater matrix. Herein, we integrate an aptamer-based electrochemical chip with a filtration, purification, and extraction (FPE) system for developing an alternate in-field solution for wastewater analysis. The sensing chip employs a dimeric aptamer, which is universally applicable to the wild-type, alpha, delta, and omicron variants of SARS-CoV-2. We demonstrate that the aptamer is stable in the wastewater matrix (diluted to 50%) and its binding affinity is not significantly impacted. The sensing chip demonstrates a limit of detection of 1000 copies/L (1 copy/mL), enabled by the amplification provided by the FPE system. This allows the integrated system to detect trace amounts of the virus in native wastewater and categorize the amount of contamination into trace (<10 copies/mL), medium (10-1000 copies/mL), or high (>1000 copies/mL) levels, providing a viable wastewater analysis solution for in-field use.

New Frontier in Terahertz Technologies for Virus Sensing

The recent pandemic of SARS-CoV-2 virus has made evident critical issues relating to virus sensing and the need for deployable tools for adequate, rapid, effective viral recognition on a large-scale. Although many conventional molecular and immuno-based techniques are widely used for these purposes, they still have some drawbacks concerning sensitivity, safety, laboriousness, long-term collection and data analysis. Therefore, new rapidly emerging approaches have been introduced such as terahertz (THz)-based technologies. In this contribution, we summarize the emerging THz radiation technology, its solutions and applications for high-sensitivity viral detection. © 2022 by the authors.

Dual-mode visual detection strategies of viable pathogens for point-of-care testing

Here, we introduce a power-free foldable poly(methyl methacrylate) (PMMA) microdevice fully integrating DNA extraction, amplification, and visual detection, realized in novel dual modes – colorimetric and aggregate formation – using 4-Aminoantipyrine (4-AP) for monitoring pathogens. The microdevice contains two parts: reaction and detection zones. A sealing film was utilized to connect the two zones and make the device foldable. The FTA card was deposited in the reaction zone for DNA extraction, followed by loop-mediated isothermal amplification (LAMP) at 65 °C for 45 min. When the detection zone is folded toward the reaction zone, paper discs modified with 4-AP placed in the detection zone are delivered to the reaction zone. Specifically, in the presence of LAMP amplicons, 4-AP is oxidized into antipyrine red or generates aggregates by interacting with copper sulfate, forming copper hybrid nanostructure (Cu-hNs). In the absence of LAMP amplicons, 4-AP is not oxidized and maintains yellow color or fails to form aggregates. Furthermore, we introduced the ethidium homodimer-1 (EthD-1) to identify viable bacteria. EthD-1 penetrated the compromised membranes of nonviable cells and prevented further DNA amplification by intercalating with the DNA. In this way, only samples containing viable cells displayed color change or formed aggregates upon reaction with 4-AP. Using this method, SARS-CoV-2 RNA and Enterococcus faecium were identified by naked eye, with the limit of detection of 103 copies/μL and 102 CFU/mL, respectively, within 60 min. The introduced microdevice can be used for rapidly monitoring viable pathogens and controlling outbreaks of infectious disease in resource-limited settings. © 2022 Elsevier B.V.

Nanotechnology-Enabled Biosensors: A Review of Fundamentals, Design Principles, Materials, and Applications.

Biosensors are modern engineering tools that can be widely used for various technological applications. In the recent past, biosensors have been widely used in a broad application spectrum including industrial process control, the military, environmental monitoring, health care, microbiology, and food quality control. Biosensors are also used specifically for monitoring environmental pollution, detecting toxic elements' presence, the presence of bio-hazardous viruses or bacteria in organic matter, and biomolecule detection in clinical diagnostics. Moreover, deep medical applications such as well-being monitoring, chronic disease treatment, and in vitro medical examination studies such as the screening of infectious diseases for early detection. The scope for expanding the use of biosensors is very high owing to their inherent advantages such as ease of use, scalability, and simple manufacturing process. Biosensor technology is more prevalent as a large-scale, low cost, and enhanced technology in the modern medical field. Integration of nanotechnology with biosensors has shown the development path for the novel sensing mechanisms and biosensors as they enhance the performance and sensing ability of the currently used biosensors. Nanoscale dimensional integration promotes the formulation of biosensors with simple and rapid detection of molecules along with the detection of single biomolecules where they can also be evaluated and analyzed critically. Nanomaterials are used for the manufacturing of nano-biosensors and the nanomaterials commonly used include nanoparticles, nanowires, carbon nanotubes (CNTs), nanorods, and quantum dots (QDs). Nanomaterials possess various advantages such as color tunability, high detection sensitivity, a large surface area, high carrier capacity, high stability, and high thermal and electrical conductivity. The current review focuses on nanotechnology-enabled biosensors, their fundamentals, and architectural design. The review also expands the view on the materials used for fabricating biosensors and the probable applications of nanotechnology-enabled biosensors.